Detalles de la búsqueda
1.
The 'totality-of-the-evidence' approach in the development of PF-06438179/GP1111, an infliximab biosimilar, and in support of its use in all indications of the reference product.
Therap Adv Gastroenterol
; 12: 1756284819852535, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31223341
Resultados
1 -
1
de 1
1
Próxima >
>>